This menu provides the list of EV miRNAs identified by high-throughput analyses.
Refresh all contents
Search:
Dataset accession
miRBase accession
Mature name
Orthologous group
Superdomain:
All
Prokaryote
Eukaryote
Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
By species
Homo sapiens
In vitro/In vivo
In vitro
In vivo
By sample type
Drug-resistant acute lymphoblastic leukemia cell (CCRF-CEM MDR variant VLB100)
Metastatic gastric cacncer cell (AZP7a)
Plasma
By sample status
Normal
Sample A_Biooscientific
Sample A_Illumina
Sample A_NEB
Sample B_Biooscientific
Sample B_NEB
Sample C_NEB
Type 1 diabetes
Maximum false positive rate (FPR):
Maximum true positive rate (TPR):
- FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
- TPR is the percentile of miRNA among the present miRNAs.
Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:
100
200
All
The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.
Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.
Mature name
miRBase accession
FPR
TPR
Publication
Orthologous group
Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-330-3p
MIMAT0000751
0.0e+0
3.8e-1
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line.
PLoS One. 2010 Oct 8;5(10):e13247. doi: 10.1371/journal.pone.0013247.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
6.4e-10
4.8e-1
Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits.
Mol Cancer. 2012 Jun 8;11:37. doi: 10.1186/1476-4598-11-37.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
0.0e+0
3.4e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
0.0e+0
4.2e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
0.0e+0
3.7e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
0.0e+0
3.4e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
0.0e+0
3.6e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
0.0e+0
3.6e-1
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
BMC Genomics. 2013 May 10;14:319. doi: 10.1186/1471-2164-14-319.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
5.2e-3
4.5e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000200_2
21
/
0
/
21
hsa-miR-330-3p
MIMAT0000751
3.4e-3
4.7e-1
Plasma-derived exosome characterization reveals a distinct microRNA signature in long duration Type 1 diabetes.
Sci Rep. 2017 Jul 20;7(1):5998. doi: 10.1038/s41598-017-05787-y.
MIPF0000200_2
21
/
0
/
21
[1]